Topical review on monitoring tetrahydrocannabinol in breath

  title={Topical review on monitoring tetrahydrocannabinol in breath},
  author={Hamed Mirzaei and Allen O'brien and Nishat Tasnim and Adithya Ravishankara and Hamed Tahmooressi and Mina Hoorfar},
  journal={Journal of Breath Research},
Legalization of cannabis for recreational use has compelled governments to seek new tools to accurately monitor Δ9-tetrahydrocannabinol (Δ9-THC) and understand its effect on impairment. Various methods have been employed to measure Δ9-THC, and its respective metabolites, in different biological matrices. Recently, breath analysis has gained interest as a non-invasive method for the detection of chemicals that are either produced as part of biological processes or are absorbed from the… 

Indeterminacy of cannabis impairment and ∆9-tetrahydrocannabinol (∆9-THC) levels in blood and breath

Analysis of breath samples revealed the presence of transient cannabinoids such as cannabigerol, cannabichromene, and ∆9-tetrahydrocannabivarin during the peak impairment window, suggesting that these compounds may be key indicators of recent cannabis use through inhalation.

A comprehensive breath test that confirms recent use of inhaled cannabis within the impairment window

An inhaled cannabis recent use test that correlates with impairment and helps protect against wrongful prosecution and workplace discrimination is described.

Breathomics: Review of Sample Collection and Analysis, Data Modeling and Clinical Applications

It is concluded that analyzing breath metabolites (both volatile and nonvolatile) is valuable in disease diagnoses, and therefore it is believed that breathomics will turn into a promising noninvasive discipline in biomarker discovery and early disease detection in personalized medicine.

Fabrication of SnO2 Composite Nanofiber-Based Gas Sensor Using the Electrospinning Method for Tetrahydrocannabinol (THC) Detection

It is shown that the proposed metal oxide semiconductor sensor for the detection of volatile organic compounds (VOCs) outperforms the commercial sensor when it is embedded inside the channel and compared with that of a commercial sensor.



Detection of ∆9-tetrahydrocannabinol in exhaled breath after cannabis smoking and comparison with oral fluid

This study gives further support to the possibility of using exhaled breath as a new matrix to document exposure to drugs, particularly for cannabis.

Detection of drugs of abuse in exhaled breath from users following recovery from intoxication.

This study gives further support to the possibility of developing exhaled breath into a new matrix for drugs-of-abuse testing by extending the number of analytes that are documented to be detectable in breath.

Cannabinoids in exhaled breath following controlled administration of smoked cannabis.

Breath may offer an alternative matrix for identifying recent driving under the influence of cannabis, but currently sensitivity is limited to a short detection window (0.5-2 h).

GC/MS and EMIT analyses for delta 9-tetrahydrocannabinol metabolites in plasma and urine of human subjects.

In plasma, THC concentration provided the best indication of recent (less than 6 hr) smoking and in enzyme-hydrolyzed urine, 8 beta, 11-dihydroxy-THC at high concentration was identified in the earliest voidings, falling rapidly to the limit of detection before 22 hr in most subjects.

Tetrahydrocannabinol (THC) Detection using Semiconductor-enriched Single-Walled Carbon Nanotube Chemiresistors.

It is shown that chemiresistor devices fabricated from s-SWCNT ink using dielectrophoresis can be incorporated into a hand-held breathalyzer with sensitivity toward THC generated from a bubbler containing analytical standard in ethanol and a heated sample evaporator that releases compounds from steel wool.

Review of Biologic Matrices (Urine, Blood, Hair) as Indicators of Recent or Ongoing Cannabis Use

The cannabis influence factor was demonstrated as a better tool to interpret the concentrations of THC and its metabolites in blood in forensic cases and therefore it was proposed to assume absolute driving inability because of cannabis intoxication from a CIF ≥10.

On-site oral fluid Δ9-tetrahydrocannabinol (THC) screening after controlled smoked, vaporized, and oral cannabis administration

Evaluated sensitivity, specificity, and efficiency of the Dräger DrugTest® 5000 [DT5000] and Alere™ DDS2 [DDS2] at various OF THC confirmatory cutoffs following controlled smoked, vaporized, and edible cannabis in frequent and occasional smokers to improve interpretation of cannabinoid OF results.